Concepedia

Thuy Tran

TT

28

Publications

2.3K

Citations

20

H-Index

1989

Active since

Affiliations

Yale University(Current)

University of Saint Joseph

Yale Cancer Center

GlaxoSmithKline (United Kingdom)

University of California, Irvine

Thuy Tran is an author at Yale University specializing in medicine, immunology, and pathology.

ORCID

Top concepts

Publications per year

1989–2024

28

Publications

28

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

Jeffrey S. Weber, Matteo S. Carlino, Adnan Khattak et al. · The Lancet · 2024 · 598 citations

, , +7

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Kurt A. Schalper, Scott Gettinger et al. · The Lancet Oncology · 2020 · 523 citations · Full text

, , +11

Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

Harriet M. Kluger, Veronica Chiang, Amit Mahajan et al. · Journal of Clinical Oncology · 2018 · 275 citations

Creating a political image: Shaping appearance and manipulating the vote

Shawn W. Rosenberg, Shulamit Kahn, Thuy Tran et al. · Political Behavior · 1993 · 90 citations · Full text

, , +6

Creating a political image: Shaping appearance and manipulating the vote

Shawn W. Rosenberg, Shulamit Kahn, Thuy Tran · Political Behavior · 1991 · 89 citations

, , +6

Rows per page

1–5 of 28